The Enterprise Value as of January 2026 (TTM) for Allarity Therapeutics, Inc. (ALLR) is 1.27M

According to Allarity Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.27M. This represents a change of -131.92% compared to the average of -3994134.52 of the last 4 quarters.

Allarity Therapeutics, Inc. (ALLR) Historical Enterprise Value (quarterly & annually)

How has ALLR Enterprise Value performed in the past?

The mean historical Enterprise Value of Allarity Therapeutics, Inc. over the last ten years is 73.79M. The current 1.27M Enterprise Value has changed 72.77% with respect to the historical average. Over the past ten years (40 quarters), ALLR's Enterprise Value was at its highest in in the September 2020 quarter at 2.96B. The Enterprise Value was at its lowest in in the June 2024 quarter at -14512739.60.

Allarity Therapeutics, Inc. (ALLR) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Allarity Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Allarity Therapeutics, Inc. (ALLR) Average Enterprise Value

How has ALLR Enterprise Value performed in the past?

The current Enterprise Value of Allarity Therapeutics, Inc. (ALLR) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Allarity Therapeutics, Inc. (ALLR) Enterprise Value vs. Peers

How is ALLR’s Enterprise Value compared to its peers?

Allarity Therapeutics, Inc.’s Enterprise Value is less than Cingulate Inc. (30.53M), greater than Processa Pharmaceuticals, Inc. (806.10K), less than BriaCell Therapeutics Corp. (5.46M), less than Lexaria Bioscience Corp. (10.43M), less than Entero Therapeutics, Inc. (7.90M), less than Lixte Biotechnology Holdings, Inc. (14.90M), greater than Clearside Biomedical, Inc. (-1382718.00), less than Kairos Pharma, Ltd. (8.22M), less than Curis, Inc. (33.32M), less than CASI Pharmaceuticals, Inc. (29.51M),

Build a custom stock screener for Allarity Therapeutics, Inc. (ALLR) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Allarity Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Allarity Therapeutics, Inc. (ALLR) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Allarity Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.